{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:09:03Z","timestamp":1760854143189,"version":"3.37.3"},"reference-count":5,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2020,8,6]]},"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1136\/jnnp-2020-324279","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T21:21:29Z","timestamp":1598649689000},"page":"1361-1362","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":22,"title":["Antiganglioside antibodies in Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection"],"prefix":"10.1136","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9125-3198","authenticated-orcid":false,"given":"Carlo","family":"Civardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Collini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinha Joan","family":"Geda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Geda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"2024120316350536000_91.12.1361.1","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano","year":"2020","journal-title":"N Engl J Med"},{"key":"2024120316350536000_91.12.1361.2","first-page":"30109","article-title":"Guillain Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence?","volume":"4422","author":"Zhao","year":"2020","journal-title":"Lancet Neurol"},{"key":"2024120316350536000_91.12.1361.3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt285"},{"key":"2024120316350536000_91.12.1361.4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41423-020-0388-9","article-title":"Physiology of gangliosides and the role of antiganglioside antibodies in human diseases","volume":"17","author":"Cutillo","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"2024120316350536000_91.12.1361.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007695","article-title":"Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barr\u00e9 syndrome in Brazil","volume":"13","author":"Rivera-Correa","year":"2019","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2020-324279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T16:26:58Z","timestamp":1733416018000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2020-324279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":5,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,11,16]]},"published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1136\/jnnp-2020-324279"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2020-324279","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"type":"print","value":"0022-3050"},{"type":"electronic","value":"1468-330X"}],"subject":[],"published":{"date-parts":[[2020,8,28]]}}}